GU - PIVOT-006

This is a Phase 3, open-label, randomized trial designed to evaluate the RFS of TURBT followed by cretostimogene grenadenorepvec versus TURBT followed by surveillance for the treatment of participants with IR-NMIBC.

Location: HH

Contact: Sierra Cugno, Sierra.Cugno@hhchealth.org

Click here to view the clinicaltrials.gov listing for this trial.

Cancer Clinical Research Office